Growth factors: Biological and clinical aspects

International Journal of Radiation Oncology Biology Physics

Volumn 43, Issue 4, 1999, Pages 877-881

  Ruifrok, A C C ^a   McBride, W H ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Radiation induced growth factors

Indexed keywords

CANCER GROWTH FACTOR; CYTOKINE; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER RESEARCH; CANCER THERAPY; CARCINOGENESIS; HEMATOPOIESIS; ONCOLOGY; PRIORITY JOURNAL; TISSUE REGENERATION;

ANIMALS; CELL COMMUNICATION; CELL DIVISION; EXTRACELLULAR MATRIX PROTEINS; FIBROSIS; GROWTH SUBSTANCES; HUMANS; MICE; RADIATION INJURIES; RECEPTOR, ERBB-2; RECEPTORS, GROWTH FACTOR; RESEARCH; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; WOUND HEALING;

EID: 0033058426     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00495-7     Document Type: Article

References (13)

1. Chiang C.S., Hong J.H., Stalder A., Sun Jr, et al. Delayed molecular responses to brain irradiation. Int J Radiat Biol. 72:1997;45-53.
2. Iwamoto K.S., McBride W.H. Production of 13-hydroxyoctadecadienoic acid and tumor necrosis factor-α by murine peritoneal macrophages in response to irradiation. Radiat Res. 139:1994;103-108.
3. Neta R. Modulation with cytokines of radiation injury suggested mechanisms of action . Environ Health Perspect. 105:(Suppl. 6):1997;1463-1465.
4. Anscher M.S., Kong F.M., Andrews K., et al. Plasma transforming growth factor beta1 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys. 41:1998;1029-1035.
5. Franko A.J., Sharplin J., Ghahary A., et al. Immunohistochemical localization of transforming growth factor beta and tumor necrosis factor alpha in the lungs of fibrosis-prone and "non-fibrosing" mice during the latent period and early phase after irradiation. Radiat Res. 147:1997;245-256.
6. Ruifrok A.C.C., Mason K.A., Lozano G., et al. Spatial and temporal patterns of expression of epidermal growth factor, transforming growth factor alpha and transforming growth factor beta 1-3 and their receptors in mouse jejunum after radiation treatment. Radiat Res. 147:1997;1-12.
7. Takahashi N., Calderone A., Izzo N.J. Jr, et al. Hypertrophic stimuli induce transforming growth factor-beta 1 expression in rat ventricular myocytes. J Clin Invest. 94:1994;1470-1476.
8. Barcellos-Hoff M.H. Latency and activation in the control of TGF-β J Mammary Gland Biol Neoplasia. 1:1996;351-361.
9. Moulder J.E., Fish B.L., Cohen E.P. Radiation nephropathy is treatable with an angiotensin converting enzyme inhibitor or an angiotensin II type-1 (AT1) receptor antagonist. Radiother Oncol. 46:1998;307-315.
10. Schmidt-Ullrich R.K., Mikkelsen R.B., Dent P., et al. Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation. Oncogene. 15:1997;1191-1197.
11. Dinney C.P.N., Parker C., Dong Z., et al. Therapy of human transitional cell carcinoma of the bladder by oral administration of the epidermal growth factor receptor protein tyrosinekinase inhibitor, 4,5-dianilinophthalimide. Clin Cancer Res. 3:1997;161-168.
12. Perrotte P, Matusmoto T, Inoue K; et al. Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice. Clin Cancer Res. In press.
13. Farese A.M., MacVittie T.J. Efficacy of Mpl ligands and other thrombopoietic cytokines in animal models. Kuter D.J., Hunt P., Sheridan W., Zucker-Franklin D. Thrombopoiesis and thrombopoietins: Molecular, cellular, preclinical, and clinical biology. 1991;321 Humana Press, Totawa, NJ.